Amanda L Eiden, Yi Zheng, Kevin M Bakker, Dong Wang, Marcie Fisher-Borne
{"title":"Trends in vaccination in pharmacy and medical settings among Medicaid recipients in the United States, 2018-2023: a claims analysis.","authors":"Amanda L Eiden, Yi Zheng, Kevin M Bakker, Dong Wang, Marcie Fisher-Borne","doi":"10.1080/14760584.2026.2715854","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Medicaid beneficiaries typically have low vaccination rates, in part due to limited access. Pharmacies provide easy-to-access locations for vaccination.</p><p><strong>Research design and methods: </strong>This was a retrospective analysis of trends in pharmacy-based vaccination by age and race or ethnicity among Medicaid recipients aged ≥9 from 1 January 2018 (before the COVID-19 pandemic) to 31 December 2023. The percentage of all vaccinations administered at pharmacies and the overall percentage change in vaccination rates were determined.</p><p><strong>Results: </strong>With some exceptions, overall routine and seasonal vaccination rates remained lower in 2023 than in 2018-2019. This was observed for human papillomavirus (HPV), influenza, and tetanus-containing (Tdap/Td) vaccines in adolescents and for hepatitis A, influenza, meningococcal, pneumococcal, and Tdap/Td vaccines in various adult age groups. The percentage of routine and seasonal vaccinations administered at pharmacies increased over the study period among adults, with increases of 5.2-17.5 percentage points for hepatitis A, hepatitis B, HPV, meningococcal, pneumococcal, and tetanus-containing vaccines among those aged 19-49. Across age groups, pharmacy-based vaccination was most frequent in White enrollees, followed by Black and then Hispanic enrollees, with smaller differentials in adults aged ≥65.</p><p><strong>Conclusions: </strong>Generally overall vaccine administration rates declined in Medicaid beneficiaries; however, the proportion administered at pharmacies increased.</p>","PeriodicalId":12326,"journal":{"name":"Expert Review of Vaccines","volume":"25 1","pages":"2715854"},"PeriodicalIF":5.6000,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert Review of Vaccines","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/14760584.2026.2715854","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/8/14 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Medicaid beneficiaries typically have low vaccination rates, in part due to limited access. Pharmacies provide easy-to-access locations for vaccination.
Research design and methods: This was a retrospective analysis of trends in pharmacy-based vaccination by age and race or ethnicity among Medicaid recipients aged ≥9 from 1 January 2018 (before the COVID-19 pandemic) to 31 December 2023. The percentage of all vaccinations administered at pharmacies and the overall percentage change in vaccination rates were determined.
Results: With some exceptions, overall routine and seasonal vaccination rates remained lower in 2023 than in 2018-2019. This was observed for human papillomavirus (HPV), influenza, and tetanus-containing (Tdap/Td) vaccines in adolescents and for hepatitis A, influenza, meningococcal, pneumococcal, and Tdap/Td vaccines in various adult age groups. The percentage of routine and seasonal vaccinations administered at pharmacies increased over the study period among adults, with increases of 5.2-17.5 percentage points for hepatitis A, hepatitis B, HPV, meningococcal, pneumococcal, and tetanus-containing vaccines among those aged 19-49. Across age groups, pharmacy-based vaccination was most frequent in White enrollees, followed by Black and then Hispanic enrollees, with smaller differentials in adults aged ≥65.
Conclusions: Generally overall vaccine administration rates declined in Medicaid beneficiaries; however, the proportion administered at pharmacies increased.
期刊介绍:
Expert Review of Vaccines (ISSN 1476-0584) provides expert commentary on the development, application, and clinical effectiveness of new vaccines. Coverage includes vaccine technology, vaccine adjuvants, prophylactic vaccines, therapeutic vaccines, AIDS vaccines and vaccines for defence against bioterrorism. All articles are subject to rigorous peer-review.
The vaccine field has been transformed by recent technological advances, but there remain many challenges in the delivery of cost-effective, safe vaccines. Expert Review of Vaccines facilitates decision making to drive forward this exciting field.